Literature DB >> 10893215

Transglutaminase-mediated fibronectin multimerization in lung endothelial matrix in response to TNF-alpha.

R Chen1, B Gao, C Huang, B Olsen, R F Rotundo, F Blumenstock, T M Saba.   

Abstract

Exposure of lung endothelial monolayers to tumor necrosis factor (TNF)-alpha causes a rearrangement of the fibrillar fibronectin (FN) extracellular matrix and an increase in protein permeability. Using calf pulmonary artery endothelial cell layers, we determined whether these changes were mediated by FN multimerization due to enhanced transglutaminase activity after TNF-alpha (200 U/ml) for 18 h. Western blot analysis indicated that TNF-alpha decreased the amount of monomeric FN detected under reducing conditions. Analysis of (125)I-FN incorporation into the extracellular matrix confirmed a twofold increase in high molecular mass (HMW) FN multimers stable under reducing conditions (P < 0.05). Enhanced formation of such HMW FN multimers was associated with increased cell surface transglutaminase activity (P < 0.05). Calf pulmonary artery endothelial cells pretreated with TNF-alpha also formed nonreducible HMW multimers of FN when layered on surfaces precoated with FN. Inhibitors of transglutaminase blocked the TNF-alpha-induced formation of nonreducible HMW multimers of FN but did not prevent either disruption of the FN matrix or the increase in monolayer permeability. Thus increased cell surface transglutaminase after TNF-alpha exposure initiates the enhanced formation of nonreducible HMW FN multimers but did not cause either the disruption of the FN matrix or the increase in endothelial monolayer permeability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893215     DOI: 10.1152/ajplung.2000.279.1.L161

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  5 in total

Review 1.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

2.  Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules.

Authors:  Keith C Olsen; Amali P Epa; Ajit A Kulkarni; R Matthew Kottmann; Claire E McCarthy; Gail V Johnson; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

3.  Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which Contributes to Lung Injury.

Authors:  Michael G Sugiyama; Asela Gamage; Roman Zyla; Susan M Armstrong; Suzanne Advani; Andrew Advani; Changsen Wang; Warren L Lee
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

4.  Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.

Authors:  Nathaly Espitia Pinzón; John J P Brevé; John G J M Bol; Benjamin Drukarch; Wia Baron; Anne-Marie van Dam
Journal:  J Neuroinflammation       Date:  2017-12-28       Impact factor: 8.322

5.  Down-Regulation of Transglutaminase 2 Stimulates Redifferentiation of Dedifferentiated Chondrocytes through Enhancing Glucose Metabolism.

Authors:  Kyoung-Won Ko; Bogyu Choi; Sunghyun Park; Yoshie Arai; Won Chul Choi; Joong-Myung Lee; Hojae Bae; In-Bo Han; Soo-Hong Lee
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.